medication assisted treatment and pregnancyasadsonline.com/handouts/2018/f3 handouts 2018...1st...

23
Medication Assisted Treatment and Pregnancy

Upload: others

Post on 05-Jul-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Medication Assisted

Treatment and

Pregnancy

Goals and Objectives

Goals

To locate whatrsquos the best practice for treating pregnant women dependent to opiates

To locate whatrsquos effective practice for treating newborns dependant to opiates

Educate clinicians on appropriate and effective treatment for patients served

Objectives

The effectiveness of methadone with opiate dependent women who are pregnant

Identify and understand neonatal abstinence syndrome

The application of the Finnegan scoring system and its effectiveness in the treatment of NAS

World Health Organization and Methadone

Medicine for pain and palliative care

There are four Opioid Analgesics

Codeine

Fentanyl

Morphine

Methadone

This Photo by Unknown Author is licensed under CC BY-SA

Heroin and Prescription Drug Use

Heroin overdose in 2010 was 8 in 2015 it

increased to 25

Prescription opioid use increased by 41

In 2010 51 Million Individuals reported

nonmedical prescription abuse

71 Gain their prescriptions from friends

or family member and brought or taken

without permission This Photo by Unknown Author is licensed under CC BY

Women Pregnancy and Opiate Use

44 of pregnant women are using illicit drugs

1 of pregnant women in the US are found using illicit opioids

Heroin use during pregnancy can lead to

Fetal Death

Infant Morbidity

Retardation

Placental Insufficiency

Preeclampsia

Premature Rupture of Membranes

Identifying Pregnant Women in MAT

Pregnancy Testing (Admission and while engaged in

treatment)

Sharing Results

Be in tune with your judgements (PAUSE)

Locating Prenatal Care

Methadone Friendly OBGYN

Patient Education

Mommys Emotional State

Reassure mom her baby is safe

Counselor Education and Training

Medical Director

Policy Procedure

Medication Increase and Decrease

Methadone and Baby

Methadone and Mommy

Medical Staff (The Clinic and the OBGYN)

Communication about addiction and treatment

Counseling

Split Dosing (Timing is everything)

Trimesters

1st Trimester ndash Education Morning Sickness

(Zofran)and Reassurance

2nd Trimester ndash Dose Stability and Prenatal

Follow Up (High risk pregnancy)-

Ultrasound

3rd Trimester ndash Due Date Preterm Infants

C Section or Natural Birth

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 2: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Goals and Objectives

Goals

To locate whatrsquos the best practice for treating pregnant women dependent to opiates

To locate whatrsquos effective practice for treating newborns dependant to opiates

Educate clinicians on appropriate and effective treatment for patients served

Objectives

The effectiveness of methadone with opiate dependent women who are pregnant

Identify and understand neonatal abstinence syndrome

The application of the Finnegan scoring system and its effectiveness in the treatment of NAS

World Health Organization and Methadone

Medicine for pain and palliative care

There are four Opioid Analgesics

Codeine

Fentanyl

Morphine

Methadone

This Photo by Unknown Author is licensed under CC BY-SA

Heroin and Prescription Drug Use

Heroin overdose in 2010 was 8 in 2015 it

increased to 25

Prescription opioid use increased by 41

In 2010 51 Million Individuals reported

nonmedical prescription abuse

71 Gain their prescriptions from friends

or family member and brought or taken

without permission This Photo by Unknown Author is licensed under CC BY

Women Pregnancy and Opiate Use

44 of pregnant women are using illicit drugs

1 of pregnant women in the US are found using illicit opioids

Heroin use during pregnancy can lead to

Fetal Death

Infant Morbidity

Retardation

Placental Insufficiency

Preeclampsia

Premature Rupture of Membranes

Identifying Pregnant Women in MAT

Pregnancy Testing (Admission and while engaged in

treatment)

Sharing Results

Be in tune with your judgements (PAUSE)

Locating Prenatal Care

Methadone Friendly OBGYN

Patient Education

Mommys Emotional State

Reassure mom her baby is safe

Counselor Education and Training

Medical Director

Policy Procedure

Medication Increase and Decrease

Methadone and Baby

Methadone and Mommy

Medical Staff (The Clinic and the OBGYN)

Communication about addiction and treatment

Counseling

Split Dosing (Timing is everything)

Trimesters

1st Trimester ndash Education Morning Sickness

(Zofran)and Reassurance

2nd Trimester ndash Dose Stability and Prenatal

Follow Up (High risk pregnancy)-

Ultrasound

3rd Trimester ndash Due Date Preterm Infants

C Section or Natural Birth

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 3: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

World Health Organization and Methadone

Medicine for pain and palliative care

There are four Opioid Analgesics

Codeine

Fentanyl

Morphine

Methadone

This Photo by Unknown Author is licensed under CC BY-SA

Heroin and Prescription Drug Use

Heroin overdose in 2010 was 8 in 2015 it

increased to 25

Prescription opioid use increased by 41

In 2010 51 Million Individuals reported

nonmedical prescription abuse

71 Gain their prescriptions from friends

or family member and brought or taken

without permission This Photo by Unknown Author is licensed under CC BY

Women Pregnancy and Opiate Use

44 of pregnant women are using illicit drugs

1 of pregnant women in the US are found using illicit opioids

Heroin use during pregnancy can lead to

Fetal Death

Infant Morbidity

Retardation

Placental Insufficiency

Preeclampsia

Premature Rupture of Membranes

Identifying Pregnant Women in MAT

Pregnancy Testing (Admission and while engaged in

treatment)

Sharing Results

Be in tune with your judgements (PAUSE)

Locating Prenatal Care

Methadone Friendly OBGYN

Patient Education

Mommys Emotional State

Reassure mom her baby is safe

Counselor Education and Training

Medical Director

Policy Procedure

Medication Increase and Decrease

Methadone and Baby

Methadone and Mommy

Medical Staff (The Clinic and the OBGYN)

Communication about addiction and treatment

Counseling

Split Dosing (Timing is everything)

Trimesters

1st Trimester ndash Education Morning Sickness

(Zofran)and Reassurance

2nd Trimester ndash Dose Stability and Prenatal

Follow Up (High risk pregnancy)-

Ultrasound

3rd Trimester ndash Due Date Preterm Infants

C Section or Natural Birth

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 4: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Heroin and Prescription Drug Use

Heroin overdose in 2010 was 8 in 2015 it

increased to 25

Prescription opioid use increased by 41

In 2010 51 Million Individuals reported

nonmedical prescription abuse

71 Gain their prescriptions from friends

or family member and brought or taken

without permission This Photo by Unknown Author is licensed under CC BY

Women Pregnancy and Opiate Use

44 of pregnant women are using illicit drugs

1 of pregnant women in the US are found using illicit opioids

Heroin use during pregnancy can lead to

Fetal Death

Infant Morbidity

Retardation

Placental Insufficiency

Preeclampsia

Premature Rupture of Membranes

Identifying Pregnant Women in MAT

Pregnancy Testing (Admission and while engaged in

treatment)

Sharing Results

Be in tune with your judgements (PAUSE)

Locating Prenatal Care

Methadone Friendly OBGYN

Patient Education

Mommys Emotional State

Reassure mom her baby is safe

Counselor Education and Training

Medical Director

Policy Procedure

Medication Increase and Decrease

Methadone and Baby

Methadone and Mommy

Medical Staff (The Clinic and the OBGYN)

Communication about addiction and treatment

Counseling

Split Dosing (Timing is everything)

Trimesters

1st Trimester ndash Education Morning Sickness

(Zofran)and Reassurance

2nd Trimester ndash Dose Stability and Prenatal

Follow Up (High risk pregnancy)-

Ultrasound

3rd Trimester ndash Due Date Preterm Infants

C Section or Natural Birth

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 5: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Women Pregnancy and Opiate Use

44 of pregnant women are using illicit drugs

1 of pregnant women in the US are found using illicit opioids

Heroin use during pregnancy can lead to

Fetal Death

Infant Morbidity

Retardation

Placental Insufficiency

Preeclampsia

Premature Rupture of Membranes

Identifying Pregnant Women in MAT

Pregnancy Testing (Admission and while engaged in

treatment)

Sharing Results

Be in tune with your judgements (PAUSE)

Locating Prenatal Care

Methadone Friendly OBGYN

Patient Education

Mommys Emotional State

Reassure mom her baby is safe

Counselor Education and Training

Medical Director

Policy Procedure

Medication Increase and Decrease

Methadone and Baby

Methadone and Mommy

Medical Staff (The Clinic and the OBGYN)

Communication about addiction and treatment

Counseling

Split Dosing (Timing is everything)

Trimesters

1st Trimester ndash Education Morning Sickness

(Zofran)and Reassurance

2nd Trimester ndash Dose Stability and Prenatal

Follow Up (High risk pregnancy)-

Ultrasound

3rd Trimester ndash Due Date Preterm Infants

C Section or Natural Birth

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 6: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Identifying Pregnant Women in MAT

Pregnancy Testing (Admission and while engaged in

treatment)

Sharing Results

Be in tune with your judgements (PAUSE)

Locating Prenatal Care

Methadone Friendly OBGYN

Patient Education

Mommys Emotional State

Reassure mom her baby is safe

Counselor Education and Training

Medical Director

Policy Procedure

Medication Increase and Decrease

Methadone and Baby

Methadone and Mommy

Medical Staff (The Clinic and the OBGYN)

Communication about addiction and treatment

Counseling

Split Dosing (Timing is everything)

Trimesters

1st Trimester ndash Education Morning Sickness

(Zofran)and Reassurance

2nd Trimester ndash Dose Stability and Prenatal

Follow Up (High risk pregnancy)-

Ultrasound

3rd Trimester ndash Due Date Preterm Infants

C Section or Natural Birth

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 7: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Patient Education

Mommys Emotional State

Reassure mom her baby is safe

Counselor Education and Training

Medical Director

Policy Procedure

Medication Increase and Decrease

Methadone and Baby

Methadone and Mommy

Medical Staff (The Clinic and the OBGYN)

Communication about addiction and treatment

Counseling

Split Dosing (Timing is everything)

Trimesters

1st Trimester ndash Education Morning Sickness

(Zofran)and Reassurance

2nd Trimester ndash Dose Stability and Prenatal

Follow Up (High risk pregnancy)-

Ultrasound

3rd Trimester ndash Due Date Preterm Infants

C Section or Natural Birth

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 8: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Medication Increase and Decrease

Methadone and Baby

Methadone and Mommy

Medical Staff (The Clinic and the OBGYN)

Communication about addiction and treatment

Counseling

Split Dosing (Timing is everything)

Trimesters

1st Trimester ndash Education Morning Sickness

(Zofran)and Reassurance

2nd Trimester ndash Dose Stability and Prenatal

Follow Up (High risk pregnancy)-

Ultrasound

3rd Trimester ndash Due Date Preterm Infants

C Section or Natural Birth

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 9: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Trimesters

1st Trimester ndash Education Morning Sickness

(Zofran)and Reassurance

2nd Trimester ndash Dose Stability and Prenatal

Follow Up (High risk pregnancy)-

Ultrasound

3rd Trimester ndash Due Date Preterm Infants

C Section or Natural Birth

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 10: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Preparing for Delivery

Takeout Medication

Hospital Admission

Contact with Nursing Staff

MAT Education

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 11: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

What is NAS

NAS ndash Neonatal Abstinence Syndrome

Neonatal withdrawal after exposure to certain drugs illicit or prescription

Newborns reframing from a group of symptoms that consistently occur together or a combination of symptoms (Chills mild tremors server crying sleeping pattern losses stools feeding patterns nasal sniffing )

Morphine or Methadone is the standard of care in the US for opioid dependent women

Buprenorphine is being use as an alternative but is not approved in the US

Presenting symptoms occurs with the first 48 to 72 hours after birth 55 to 95 of infants are exposed

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 12: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

NAS Scoring Scale

The Finnegan Neonatal Abstinence Scoring System

31 itam scale design to quantify severity of NAS and to begin NAS

treatment

Begins scoring within 2 hours of life(Baseline Score)

Administer in 4 hours intervals

NAS symptoms are weighed numerically scoring 1 ndash 5

Infants scoring 8 or greater will receive pharmacological therapy

Very comprehensive but to complex for routine use

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 13: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Scoring Process

Baby born at 2pm

Scoring is recorded 4pm or admissions to the nursery (Baseline Score)

4 hour intervals 8pm or 2 hours 6pm based on severity of symptoms

Scoring 8 or greater

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 14: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Nonpharmacologic Therapies

The Goal Minimize Stimulation

Swaddling

Skin to skin

Calorically dense formulas

Breastfeeding

Minimal sensory or environmental stimulation

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 15: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Breastfeeding

Breastfeeding in MAT is traditionally low among women

In 2011 the US Surgeon General and DHHS released A Call to Action to

Support Breastfeeding

Methadone is passed on to neonates through breastmilk

Small amount lt02 mgd no change in neonatal serum methadone

The Calming Effect

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 16: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Medications Used

20 of providers use methadone

63 Use other opioids

Initial theropy use alcohol free oral morphine sulfate 04 mgmL or

preprartion morphine hydrochloride 02 mgmL

Diluted Tincture of opium(Contains a small amount of alcohol)

Paregoric 1st agent used but decclided due to toxic side effects

Diazepam no longer used due to impaired neonatal excretion and late

on set seizures

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 17: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Babies Treatment

Three reason medication is adminstered in the hospital

1 Respiratory depression requires inpatient monitoring

2 Relapse Prevention

3 Frequent assessment by trained providers for either over or under medicate

4 Length of stay baby is released when mom is released or up to 21 days

Methadone Half Life in newborns 38 to 62 hours but its difficult to gauge in

newborns

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 18: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Postpartum

Depression and Anxiety

Baby Assessment

Supporting Mommy

DFACS

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 19: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Benfits or Purpose for Treatment

To Prevent Opioid Withdrawal Signs and

Symptoms

To Provide a Safe and Comfortable

InductionEducation

Block the Euphoric Effects of Illicit Opioids

Eliminating the Fetal Exposure to Opioids

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 20: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Talking to Family and Loved Ones

Educate ndash On Methadone

Educate ndash On Pregnancy and

Methadone

Educate ndash On Our Baby

Educate ndash On What to expect

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 21: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

This Photo by Unknown Author is licensed under CC BY-SA

The Criminal Justice System and Treatment

Inmates rights

Investigation vs Medical

Confirmation of a positive

drug screen

Coordination of Care

Ending treatment

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 22: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Research

The Opioid Exposed Newborn Assessment and Pharmacologic Management

Lauren M Jansson Martha Velez Cheryl Harrow

J Opioid Manag Author manuscript available in PMC 2009 August 19

Published in final edited form as J Opioid Manag 2009 5(1) 47ndash55

Neonatal Abstinence Syndrome Influence of a Combined InpatientOutpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population

Jerry Lee Sonia Hulman Michael Musci Jr Ellen Stang

Popul Health Manag 2015 October 1 18(5) 392ndash397 doi 101089pop20140134

North Carolina Pregnancy amp Opioid Exposure Project Neonatal Abstinence Syndrome (NAS)2017

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA

Page 23: Medication Assisted Treatment and Pregnancyasadsonline.com/handouts/2018/F3 Handouts 2018...1st Trimester – Education, Morning Sickness (Zofran)and Reassurance 2nd Trimester –

Research Continued

Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Childrenrsquos Hospital -21113

Revised 022013 by Sarah Tierney PharmD Written 092012 by Sarah

Tierney PharmD Approved 092012 J Klein MD

Pharmacologic Management of the Opioid Neonatal Abstinence Syndrome

Walter K Kraft MDabc and John N van den Anker MD PhDdefg

The Opioid dependent mother and newborn dyad non-pharmacologic care

Martha Velez MD and Lauren M Jansson MD

This Photo by Unknown Author is licensed under CC BY-SA